The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Transmucosal Drug Delivery Systems Market Research Report 2024
Synopsis
The transmucosal route includes oral, nasal, vaginal, and urethral and presents a challenge in the field of novel drug delivery technology. The transmucosal membranes are relatively permeable, have a rich blood flow and hence allow the rapid uptake of a drug into systemic circulation to avoid first pass metabolism.
The global Transmucosal Drug Delivery Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Transmucosal Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transmucosal Drug Delivery Systems.
Report Scope
The Transmucosal Drug Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transmucosal Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transmucosal Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
Acrux Limited
ALZA Corporation
DURECT Corporation
Generex Biotechnology
Segment by Type
Oral Drug Delivery
Nasal Drug Delivery
Rectal Drug Delivery
Other
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transmucosal Drug Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The transmucosal route includes oral, nasal, vaginal, and urethral and presents a challenge in the field of novel drug delivery technology. The transmucosal membranes are relatively permeable, have a rich blood flow and hence allow the rapid uptake of a drug into systemic circulation to avoid first pass metabolism.
The global Transmucosal Drug Delivery Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Transmucosal Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transmucosal Drug Delivery Systems.
Report Scope
The Transmucosal Drug Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transmucosal Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transmucosal Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
Acrux Limited
ALZA Corporation
DURECT Corporation
Generex Biotechnology
Segment by Type
Oral Drug Delivery
Nasal Drug Delivery
Rectal Drug Delivery
Other
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transmucosal Drug Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transmucosal Drug Delivery Systems Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Drug Delivery
1.2.3 Nasal Drug Delivery
1.2.4 Rectal Drug Delivery
1.2.5 Other
1.3 Market by Application
1.3.1 Global Transmucosal Drug Delivery Systems Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transmucosal Drug Delivery Systems Market Perspective (2019-2030)
2.2 Transmucosal Drug Delivery Systems Growth Trends by Region
2.2.1 Global Transmucosal Drug Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transmucosal Drug Delivery Systems Historic Market Size by Region (2019-2024)
2.2.3 Transmucosal Drug Delivery Systems Forecasted Market Size by Region (2025-2030)
2.3 Transmucosal Drug Delivery Systems Market Dynamics
2.3.1 Transmucosal Drug Delivery Systems Industry Trends
2.3.2 Transmucosal Drug Delivery Systems Market Drivers
2.3.3 Transmucosal Drug Delivery Systems Market Challenges
2.3.4 Transmucosal Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transmucosal Drug Delivery Systems Players by Revenue
3.1.1 Global Top Transmucosal Drug Delivery Systems Players by Revenue (2019-2024)
3.1.2 Global Transmucosal Drug Delivery Systems Revenue Market Share by Players (2019-2024)
3.2 Global Transmucosal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transmucosal Drug Delivery Systems Revenue
3.4 Global Transmucosal Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Transmucosal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Systems Revenue in 2023
3.5 Transmucosal Drug Delivery Systems Key Players Head office and Area Served
3.6 Key Players Transmucosal Drug Delivery Systems Product Solution and Service
3.7 Date of Enter into Transmucosal Drug Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transmucosal Drug Delivery Systems Breakdown Data by Type
4.1 Global Transmucosal Drug Delivery Systems Historic Market Size by Type (2019-2024)
4.2 Global Transmucosal Drug Delivery Systems Forecasted Market Size by Type (2025-2030)
5 Transmucosal Drug Delivery Systems Breakdown Data by Application
5.1 Global Transmucosal Drug Delivery Systems Historic Market Size by Application (2019-2024)
5.2 Global Transmucosal Drug Delivery Systems Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Transmucosal Drug Delivery Systems Market Size (2019-2030)
6.2 North America Transmucosal Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Transmucosal Drug Delivery Systems Market Size by Country (2019-2024)
6.4 North America Transmucosal Drug Delivery Systems Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transmucosal Drug Delivery Systems Market Size (2019-2030)
7.2 Europe Transmucosal Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Transmucosal Drug Delivery Systems Market Size by Country (2019-2024)
7.4 Europe Transmucosal Drug Delivery Systems Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transmucosal Drug Delivery Systems Market Size (2019-2030)
8.2 Asia-Pacific Transmucosal Drug Delivery Systems Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Region (2019-2024)
8.4 Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transmucosal Drug Delivery Systems Market Size (2019-2030)
9.2 Latin America Transmucosal Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Transmucosal Drug Delivery Systems Market Size by Country (2019-2024)
9.4 Latin America Transmucosal Drug Delivery Systems Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transmucosal Drug Delivery Systems Market Size (2019-2030)
10.2 Middle East & Africa Transmucosal Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Country (2019-2024)
10.4 Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3M
11.1.1 3M Company Detail
11.1.2 3M Business Overview
11.1.3 3M Transmucosal Drug Delivery Systems Introduction
11.1.4 3M Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.1.5 3M Recent Development
11.2 Antares Pharma
11.2.1 Antares Pharma Company Detail
11.2.2 Antares Pharma Business Overview
11.2.3 Antares Pharma Transmucosal Drug Delivery Systems Introduction
11.2.4 Antares Pharma Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.2.5 Antares Pharma Recent Development
11.3 Aveva Drug Delivery Systems
11.3.1 Aveva Drug Delivery Systems Company Detail
11.3.2 Aveva Drug Delivery Systems Business Overview
11.3.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Systems Introduction
11.3.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.3.5 Aveva Drug Delivery Systems Recent Development
11.4 Corium International
11.4.1 Corium International Company Detail
11.4.2 Corium International Business Overview
11.4.3 Corium International Transmucosal Drug Delivery Systems Introduction
11.4.4 Corium International Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.4.5 Corium International Recent Development
11.5 Acrux Limited
11.5.1 Acrux Limited Company Detail
11.5.2 Acrux Limited Business Overview
11.5.3 Acrux Limited Transmucosal Drug Delivery Systems Introduction
11.5.4 Acrux Limited Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.5.5 Acrux Limited Recent Development
11.6 ALZA Corporation
11.6.1 ALZA Corporation Company Detail
11.6.2 ALZA Corporation Business Overview
11.6.3 ALZA Corporation Transmucosal Drug Delivery Systems Introduction
11.6.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.6.5 ALZA Corporation Recent Development
11.7 DURECT Corporation
11.7.1 DURECT Corporation Company Detail
11.7.2 DURECT Corporation Business Overview
11.7.3 DURECT Corporation Transmucosal Drug Delivery Systems Introduction
11.7.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.7.5 DURECT Corporation Recent Development
11.8 Generex Biotechnology
11.8.1 Generex Biotechnology Company Detail
11.8.2 Generex Biotechnology Business Overview
11.8.3 Generex Biotechnology Transmucosal Drug Delivery Systems Introduction
11.8.4 Generex Biotechnology Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.8.5 Generex Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
